# Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl

> **NCT00533559** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 10 (actual)

## Conditions studied

- Diabetes
- Insulin Resistance

## Interventions

- **DRUG:** sodium phenylbutyrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00533559
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2010-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533559, "Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00533559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*